CAPR vs DAL · $1.62B cap vs P/E 12, rev $61.64B
Capricor Therapeutics Inc (CAPR) versus Delta Air Lines Inc (DAL) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. CAPR currently screens at market cap $1.62B.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
CAPR currently screens at market cap $1.62B. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Not investment advice. Open the CAPR and DAL stock pages for the full models.
Not investment advice.